Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Prostate Cancer is the second leading cause of death in American men after lung cancer. In 2018, 165,000 men will be diagnosed with prostate cancer. The question all men with prostate cancer need ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Guy Griffiths was diagnosed after he requested a prostate specific antigen (PSA) test from his GP.

BALTIMORE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...

Scientists are reporting a test which can predict which patients are most at risk from aggressive prostate cancer, and whether they suffer an increased chance of treatment failure. This test, reported ...

Development and validation of a novel circulating tumor cell response stratification criteria for metastatic castration-resistant prostate cancer clinical trials. This is an ASCO Meeting Abstract from ...